Asier Selas

Santiago De Compostela, GA, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A patent review of topoisomerase 1 inhibitors (2021-present).

A patent review of topoisomerase 1 inhibitors (2021-present).

Journal: Expert opinion on therapeutic patents

Published: November 14, 2025

Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB2 Agonists with Neuroprotective Effects.

Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB2 Agonists with Neuroprotective Effects.

Journal: Journal of medicinal chemistry

Published: August 12, 2025

Investigational DNA topoisomerase I inhibitors for colorectal cancer: preclinical and early phase developments.

Investigational DNA topoisomerase I inhibitors for colorectal cancer: preclinical and early phase developments.

Journal: Expert opinion on investigational drugs

Published: July 19, 2025

Targeting the adenosinergic axis in cancer immunotherapy: Insights into A2A and A2B receptors and novel clinical combination strategies.

Targeting the adenosinergic axis in cancer immunotherapy: Insights into A2A and A2B receptors and novel clinical combination strategies.

Journal: Pharmacological reviews

Published: June 19, 2025

The design and discovery of topoisomerase I inhibitors as anticancer therapies.

The design and discovery of topoisomerase I inhibitors as anticancer therapies.

Journal: Expert opinion on drug discovery

Published: March 24, 2022

Synthesis of hybrid phosphorated indenoquinolines and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.

Synthesis of hybrid phosphorated indenoquinolines and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.

Journal: Bioorganic & medicinal chemistry letters

Published: September 07, 2021

Hybrid Quinolinyl Phosphonates as Heterocyclic Carboxylate Isosteres: Synthesis and Biological Evaluation against Topoisomerase 1B (TOP1B).

Hybrid Quinolinyl Phosphonates as Heterocyclic Carboxylate Isosteres: Synthesis and Biological Evaluation against Topoisomerase 1B (TOP1B).

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 13, 2021

Simple and Fast DNA Based Sensor System for Screening of Small-Molecule Compounds Targeting Eukaryotic Topoisomerase 1.

Simple and Fast DNA Based Sensor System for Screening of Small-Molecule Compounds Targeting Eukaryotic Topoisomerase 1.

Journal: Pharmaceutics

Published: June 30, 2021

A patent review of topoisomerase I inhibitors (2016-present).

A patent review of topoisomerase I inhibitors (2016-present).

Journal: Expert opinion on therapeutic patents

Published: January 21, 2021

Fused 1,5-Naphthyridines: Synthetic Tools and Applications.

Fused 1,5-Naphthyridines: Synthetic Tools and Applications.

Journal: Molecules (Basel, Switzerland)

Published: July 13, 2020

Synthetic Strategies, Reactivity and Applications of 1,5-Naphthyridines.

Synthetic Strategies, Reactivity and Applications of 1,5-Naphthyridines.

Journal: Molecules (Basel, Switzerland)

Published: June 29, 2020

Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.

Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.

Journal: European journal of medicinal chemistry

Published: December 09, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026